Big Gain For Ampio Pharmaceuticals, Inc.
Thu, Nov 17, 2022 at 07:25 PM

Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT) rocketted at $0.03, a gain of 28.3%. On Thu, Nov 17, 2022, AMPE:NYSEMKT touched a New 2-Week Intraday Low of $0.02. The stock appeared on our News Catalysts scanner on Tue, Nov 08, 2022 at 07:22 PM in the 'SPLIT' category. From Thu, Nov 03, 2022, the stock recorded 10.00% Up Days and 27.27% Green Days
About Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT)
Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Top 10 Gainers:
- SatixFy Communications Ltd. (SATX:NYSEMKT), 96.35%
- Elevate Credit, Inc. (ELVT:NYSE), 68.87%
- Ardelyx, Inc. (ARDX:NASDAQ), 40.98%
- CytomX Therapeutics, Inc. (CTMX:NASDAQ), 32.23%
- Atour Lifestyle Holdings Limited (ATAT:NASDAQ), 30.99%
- XL Group Ltd (XL:NYSE), 30.91%
- NWTN Inc. (NWTN:NASDAQ), 29.75%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- GoHealth Inc. (GOCO:NASDAQ), 26.5%
- Conformis, Inc. (CFMS:NASDAQ), 26.4%